Robustness, evolvability, and neutrality

被引:211
作者
Wagner, A [1 ]
机构
[1] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA
关键词
molecular evolution; evolutionary novelty; innovation;
D O I
10.1016/j.febslet.2005.01.063
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Biological systems, from macromolecules to whole organisms, are robust if they continue to function, survive, or reproduce when faced with mutations, environmental change, and internal noise. I focus here on biological systems that are robust to mutations and ask whether such systems are more or less evolvable, in the sense that they can acquire novel properties. The more robust a system is, the more mutations in it are neutral, that is, without phenotypic effect. I argue here that such neutral change - and thus robustness - can be a key to future evolutionary innovation, if one accepts that neutrality is not an essential feature of a mutation. That is, a once neutral mutation may cause phenotypic effects in a changed environment or genetic background. I argue that most, if not all, neutral mutations are of this sort, and that the essentialist notion of neutrality should be abandoned. This perspective reconciles two opposing views on the forces dominating organismal evolution, natural selection and random drift: neutral mutations occur and are especially abundant in robust systems, but they do not remain neutral indefinitely, and eventually become visible to natural selection, where some of them lead to evolutionary innovations. (c) 2005 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:1772 / 1778
页数:7
相关论文
共 58 条
[1]   The 'evolvability' of promiscuous protein functions [J].
Aharoni, A ;
Gaidukov, L ;
Khersonsky, O ;
Gould, SM ;
Roodveldt, C ;
Tawfik, DS .
NATURE GENETICS, 2005, 37 (01) :73-76
[2]  
[Anonymous], 1998, Cells, Embryos, and Evolution
[3]   Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect [J].
Astrom, K ;
Cohen, JE ;
Willett-Brozick, JE ;
Aston, CE ;
Baysal, BE .
HUMAN GENETICS, 2003, 113 (03) :228-237
[4]   FUNCTIONAL SITES IN THE 5' REGION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA FORM DEFINED STRUCTURAL DOMAINS [J].
BAUDIN, F ;
MARQUET, R ;
ISEL, C ;
DARLIX, JL ;
EHRESMANN, B ;
EHRESMANN, C .
JOURNAL OF MOLECULAR BIOLOGY, 1993, 229 (02) :382-397
[5]   THE NEUROTROPHIC FACTOR NEUROLEUKIN IS 90-PERCENT HOMOLOGOUS WITH PHOSPHOHEXOSE ISOMERASE [J].
CHAPUT, M ;
CLAES, V ;
PORTETELLE, D ;
CLUDTS, I ;
CRAVADOR, A ;
BURNY, A ;
GRAS, H ;
TARTAR, A .
NATURE, 1988, 332 (6163) :454-455
[6]   Inferring nonneutral evolution from human-chimp-mouse orthologous gene trios [J].
Clark, AG ;
Glanowski, S ;
Nielsen, R ;
Thomas, PD ;
Kejariwal, A ;
Todd, MA ;
Tanenbaum, DM ;
Civello, D ;
Lu, F ;
Murphy, B ;
Ferriera, S ;
Wang, G ;
Zheng, XG ;
White, TJ ;
Sninsky, JJ ;
Adams, MD ;
Cargill, M .
SCIENCE, 2003, 302 (5652) :1960-1963
[7]  
Comeron JM, 1996, GENETICS, V144, P1053
[8]  
Comeron JM, 1999, GENETICS, V151, P239
[9]  
DAWKINS R, 1989, ARTIFICIAL LIFE P IN
[10]   EXTENSIVE SEQUENCE-SPECIFIC INFORMATION THROUGHOUT THE CAR RRE, THE TARGET SEQUENCE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN [J].
DAYTON, ET ;
KONINGS, DAM ;
POWELL, DM ;
SHAPIRO, BA ;
BUTINI, L ;
MAIZEL, JV ;
DAYTON, AI .
JOURNAL OF VIROLOGY, 1992, 66 (02) :1139-1151